These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 15640155

  • 1. Systematic evaluation of anti-apoptotic growth factor signaling in vascular smooth muscle cells. Only phosphatidylinositol 3'-kinase is important.
    Vantler M, Caglayan E, Zimmermann WH, Bäumer AT, Rosenkranz S.
    J Biol Chem; 2005 Apr 08; 280(14):14168-76. PubMed ID: 15640155
    [Abstract] [Full Text] [Related]

  • 2. N-Ethylmaleimide inhibits platelet-derived growth factor BB-stimulated Akt phosphorylation via activation of protein phosphatase 2A.
    Yellaturu CR, Bhanoori M, Neeli I, Rao GN.
    J Biol Chem; 2002 Oct 18; 277(42):40148-55. PubMed ID: 12171932
    [Abstract] [Full Text] [Related]

  • 3. PYK2 signaling is required for PDGF-dependent vascular smooth muscle cell proliferation.
    Perez J, Torres RA, Rocic P, Cismowski MJ, Weber DS, Darley-Usmar VM, Lucchesi PA.
    Am J Physiol Cell Physiol; 2011 Jul 18; 301(1):C242-51. PubMed ID: 21451101
    [Abstract] [Full Text] [Related]

  • 4. Antiproliferative activity of NQ304, a synthetic 1,4-naphthoquinone, is mediated via the suppressions of the PI3K/Akt and ERK1/2 signaling pathways in PDGF-BB-stimulated vascular smooth muscle cells.
    Kim TJ, Yun YP.
    Vascul Pharmacol; 2007 Jan 18; 46(1):43-51. PubMed ID: 16875883
    [Abstract] [Full Text] [Related]

  • 5. Disruption of platelet-derived growth factor-dependent phosphatidylinositol 3-kinase and phospholipase Cγ 1 activity abolishes vascular smooth muscle cell proliferation and migration and attenuates neointima formation in vivo.
    Caglayan E, Vantler M, Leppänen O, Gerhardt F, Mustafov L, Ten Freyhaus H, Kappert K, Odenthal M, Zimmermann WH, Tallquist MD, Rosenkranz S.
    J Am Coll Cardiol; 2011 Jun 21; 57(25):2527-38. PubMed ID: 21679854
    [Abstract] [Full Text] [Related]

  • 6. Matrix metalloproteinase-2 expression by vascular smooth muscle cells is mediated by both stimulatory and inhibitory signals in response to growth factors.
    Risinger GM, Hunt TS, Updike DL, Bullen EC, Howard EW.
    J Biol Chem; 2006 Sep 08; 281(36):25915-25. PubMed ID: 16854986
    [Abstract] [Full Text] [Related]

  • 7. Platelet-derived growth factor-BB-mediated activation of Akt suppresses smooth muscle-specific gene expression through inhibition of mitogen-activated protein kinase and redistribution of serum response factor.
    Kaplan-Albuquerque N, Garat C, Desseva C, Jones PL, Nemenoff RA.
    J Biol Chem; 2003 Oct 10; 278(41):39830-8. PubMed ID: 12882977
    [Abstract] [Full Text] [Related]

  • 8. Modification of PI3K- and MAPK-dependent chemotaxis in aortic vascular smooth muscle cells by protein kinase CbetaII.
    Campbell M, Trimble ER.
    Circ Res; 2005 Feb 04; 96(2):197-206. PubMed ID: 15591231
    [Abstract] [Full Text] [Related]

  • 9. Ets-1 mediates platelet-derived growth factor-BB-induced thrombomodulin expression in human vascular smooth muscle cells.
    Lo IC, Lin TM, Chou LH, Liu SL, Wu LW, Shi GY, Wu HL, Jiang MJ.
    Cardiovasc Res; 2009 Mar 01; 81(4):771-9. PubMed ID: 19091791
    [Abstract] [Full Text] [Related]

  • 10. Platelet-derived growth factor-BB, insulin-like growth factor-I, and phorbol ester activate different signaling pathways for stimulation of vascular smooth muscle cell migration.
    Pukac L, Huangpu J, Karnovsky MJ.
    Exp Cell Res; 1998 Aug 01; 242(2):548-60. PubMed ID: 9683541
    [Abstract] [Full Text] [Related]

  • 11. Platelet-derived growth factor induces tissue factor expression in vascular smooth muscle cells via activation of Egr-1.
    Kamimura M, Bea F, Akizawa T, Katus HA, Kreuzer J, Viedt C.
    Hypertension; 2004 Dec 01; 44(6):944-51. PubMed ID: 15492129
    [Abstract] [Full Text] [Related]

  • 12. Phosphatidylinositol 3-kinase is required for growth factor-induced amino acid uptake by vascular smooth muscle cells.
    Higaki M, Shimokado K.
    Arterioscler Thromb Vasc Biol; 1999 Sep 01; 19(9):2127-32. PubMed ID: 10479654
    [Abstract] [Full Text] [Related]

  • 13. Rat aortic smooth muscle cell density affects activation of MAP kinase and Akt by menadione and PDGF homodimer BB.
    Li XA, Bianchi C, Sellke FW.
    J Surg Res; 2001 Oct 01; 100(2):197-204. PubMed ID: 11592793
    [Abstract] [Full Text] [Related]

  • 14. Dual role of SRC homology domain 2-containing inositol phosphatase 2 in the regulation of platelet-derived growth factor and insulin-like growth factor I signaling in rat vascular smooth muscle cells.
    Sasaoka T, Kikuchi K, Wada T, Sato A, Hori H, Murakami S, Fukui K, Ishihara H, Aota R, Kimura I, Kobayashi M.
    Endocrinology; 2003 Sep 01; 144(9):4204-14. PubMed ID: 12933696
    [Abstract] [Full Text] [Related]

  • 15. Platelet-derived growth factor-BB-induced hypertrophy of peritubular smooth muscle cells is mediated by activation of p38 MAP-kinase and of Rho-kinase.
    Romano F, Chiarenza C, Palombi F, Filippini A, Padula F, Ziparo E, De Cesaris P.
    J Cell Physiol; 2006 Apr 01; 207(1):123-31. PubMed ID: 16270352
    [Abstract] [Full Text] [Related]

  • 16. Hypoxia induces an autocrine-paracrine survival pathway via platelet-derived growth factor (PDGF)-B/PDGF-beta receptor/phosphatidylinositol 3-kinase/Akt signaling in RN46A neuronal cells.
    Zhang SX, Gozal D, Sachleben LR, Rane M, Klein JB, Gozal E.
    FASEB J; 2003 Sep 01; 17(12):1709-11. PubMed ID: 12958184
    [Abstract] [Full Text] [Related]

  • 17. Cardiotrophin-1 phosphorylates akt and BAD, and prolongs cell survival via a PI3K-dependent pathway in cardiac myocytes.
    Kuwahara K, Saito Y, Kishimoto I, Miyamoto Y, Harada M, Ogawa E, Hamanaka I, Kajiyama N, Takahashi N, Izumi T, Kawakami R, Nakao K.
    J Mol Cell Cardiol; 2000 Aug 01; 32(8):1385-94. PubMed ID: 10900165
    [Abstract] [Full Text] [Related]

  • 18. Changes in the balance of phosphoinositide 3-kinase/protein kinase B (Akt) and the mitogen-activated protein kinases (ERK/p38MAPK) determine a phenotype of visceral and vascular smooth muscle cells.
    Hayashi K, Takahashi M, Kimura K, Nishida W, Saga H, Sobue K.
    J Cell Biol; 1999 May 17; 145(4):727-40. PubMed ID: 10330402
    [Abstract] [Full Text] [Related]

  • 19. The integrin alpha2beta1 agonist, aggretin, promotes proliferation and migration of VSMC through NF-kB translocation and PDGF production.
    Chung CH, Lin KT, Chang CH, Peng HC, Huang TF.
    Br J Pharmacol; 2009 Mar 17; 156(5):846-56. PubMed ID: 19239475
    [Abstract] [Full Text] [Related]

  • 20. Ketamine, a Clinically Used Anesthetic, Inhibits Vascular Smooth Muscle Cell Proliferation via PP2A-Activated PI3K/Akt/ERK Inhibition.
    Chang Y, Li JY, Jayakumar T, Hung SH, Lee WC, Manubolu M, Sheu JR, Hsu MJ.
    Int J Mol Sci; 2017 Nov 27; 18(12):. PubMed ID: 29186909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.